FDA Approved: POMALIDOMIDE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

The FDA approved a supplemental application from Apotex Corp. for pomalidomide, allowing the generic version of pomalidomide to be marketed (ANDA 210164).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Pomalidomide (Pomalidomide)

Snippet

SUPPL AP for POMALIDOMIDE (POMALIDOMIDE)